USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | preprint |
Idioma: | por |
Título da fonte: | SciELO Preprints |
Texto Completo: | https://preprints.scielo.org/index.php/scielo/preprint/view/4505 |
Resumo: | Introduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage. |
id |
SCI-1_45a7586ee728c8913fbef84e1e35eba3 |
---|---|
oai_identifier_str |
oai:ops.preprints.scielo.org:preprint/4505 |
network_acronym_str |
SCI-1 |
network_name_str |
SciELO Preprints |
repository_id_str |
|
spelling |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACILUSO DE MEMBRANA AMNIÓTICA HUMANA DESCELULARIZADA EM ANASTOMOSES INTESTINAIS: ESTUDO EM RATOS TRATADOS COM 5-FLUOROURACILMembrana amnióticaAnastomoseQuimioterapia antitumoralAmniotic membraneAnastomosisAntitumoral chemotherapyIntroduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage.Introdução: Atualmente emerge em nosso meio aplicações mais relevantes dos derivados perinatais, por exemplo, a membrana amniótica (MA), como fonte de biomateriais para emprego em diferentes processos cicatriciais. O comprometimento anastomótico por drogas antimetabólicas como o 5-fluorouracil (5-FU) é um potencial alvo da MA. Objetivo: Avaliar os efeitos cicatriciais do uso da MA em ratos tratados com 5-FU na dose de 20 mg/kg ao 7º. dia de evolução pós-operatória quanto aos parâmetros porcentagem de colágeno tipo I (maduro), viabilidade celular, densidade microvascular e formação do tecido de granulação. Método: Utilizaram-se 32 ratos da linhagem Wistar submetidos à colotomia e colorrafia separados em 4 grupos com 8 e receberam diferentes tratamentos diariamente por via intraperitoneal até o dia do sacrifício: Solução fisiológica (C), 20 mg/kg 5-FU, 20 mg/kg 5-FU e MA, MA. Resultados: O tratamento com 20 mg/kg de 5-FU, ao 7º. dia pós-operatório induziu efeitos adversos no processo cicatricial anastomótico evidenciados pela diminuição da porcentagem de colágeno tipo I (maduro), da viabilidade celular, da densidade microvascular, da formação de crosta fibrinoleucocitária e da proliferação angiofibroblástica; o uso da MA nestas condições induziu melhora da porcentagem de colágeno tipo I (maduro). Conclusão: O tratamento com 20 mg/kg de 5-FU, ao 7º. dia pós-operatório induziu efeitos adversos no processo cicatricial anastomótico e o uso da MA nestas condições induziu melhora da porcentagem de colágeno tipo I (maduro).SciELO PreprintsSciELO PreprintsSciELO Preprints2022-07-27info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/450510.1590/SciELOPreprints.4505porhttps://preprints.scielo.org/index.php/scielo/article/view/4505/8630Copyright (c) 2022 Daniel Dantas Ferrarin, Nicolau Gregori Czeczko , Luiz Fernando Kubrusly , Osvaldo Malafaia, Eros Luiz de Sousa, João Carlos Domingues Repka, Pedro Henrique Lambach Caron, Carlos José Franco de Souza https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFerrarin, Daniel DantasCzeczko , Nicolau GregoriKubrusly , Luiz FernandoMalafaia, OsvaldoSousa, Eros Luiz deRepka, João Carlos DominguesCaron, Pedro Henrique LambachSouza , Carlos José Franco dereponame:SciELO Preprintsinstname:SciELOinstacron:SCI2022-07-27T15:04:43Zoai:ops.preprints.scielo.org:preprint/4505Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2022-07-27T15:04:43SciELO Preprints - SciELOfalse |
dc.title.none.fl_str_mv |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL USO DE MEMBRANA AMNIÓTICA HUMANA DESCELULARIZADA EM ANASTOMOSES INTESTINAIS: ESTUDO EM RATOS TRATADOS COM 5-FLUOROURACIL |
title |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
spellingShingle |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL Ferrarin, Daniel Dantas Membrana amniótica Anastomose Quimioterapia antitumoral Amniotic membrane Anastomosis Antitumoral chemotherapy |
title_short |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
title_full |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
title_fullStr |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
title_full_unstemmed |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
title_sort |
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL |
author |
Ferrarin, Daniel Dantas |
author_facet |
Ferrarin, Daniel Dantas Czeczko , Nicolau Gregori Kubrusly , Luiz Fernando Malafaia, Osvaldo Sousa, Eros Luiz de Repka, João Carlos Domingues Caron, Pedro Henrique Lambach Souza , Carlos José Franco de |
author_role |
author |
author2 |
Czeczko , Nicolau Gregori Kubrusly , Luiz Fernando Malafaia, Osvaldo Sousa, Eros Luiz de Repka, João Carlos Domingues Caron, Pedro Henrique Lambach Souza , Carlos José Franco de |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Ferrarin, Daniel Dantas Czeczko , Nicolau Gregori Kubrusly , Luiz Fernando Malafaia, Osvaldo Sousa, Eros Luiz de Repka, João Carlos Domingues Caron, Pedro Henrique Lambach Souza , Carlos José Franco de |
dc.subject.por.fl_str_mv |
Membrana amniótica Anastomose Quimioterapia antitumoral Amniotic membrane Anastomosis Antitumoral chemotherapy |
topic |
Membrana amniótica Anastomose Quimioterapia antitumoral Amniotic membrane Anastomosis Antitumoral chemotherapy |
description |
Introduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/preprint info:eu-repo/semantics/publishedVersion |
format |
preprint |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/preprint/view/4505 10.1590/SciELOPreprints.4505 |
url |
https://preprints.scielo.org/index.php/scielo/preprint/view/4505 |
identifier_str_mv |
10.1590/SciELOPreprints.4505 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/article/view/4505/8630 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
dc.source.none.fl_str_mv |
reponame:SciELO Preprints instname:SciELO instacron:SCI |
instname_str |
SciELO |
instacron_str |
SCI |
institution |
SCI |
reponame_str |
SciELO Preprints |
collection |
SciELO Preprints |
repository.name.fl_str_mv |
SciELO Preprints - SciELO |
repository.mail.fl_str_mv |
scielo.submission@scielo.org |
_version_ |
1797047829223440384 |